CIK 0002075320 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Polaryx Therapeutics, Inc.
Sign in to watch- Ticker
- PLYX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- WY
- Entity type
- operating
- Phone
- 201-940-7236
- Business address
- 140 EAST RIDGEWOOD AVENUE, SUITE 415, SOUTH TOWER, PARAMUS, NJ, 07652
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-27 | Yang Alex Keun Mo Chief Executive Officer | Purchase | +88,453 | $4.07 | $360K | 24,233,249 |
| 2026-02-18 | Landis G. Michael Chief Financial Officer | Purchase | +2,867 | $2.79 | $8K | 228,225 |
Page 1 of 1 · 2 trades